BNP Paribas Asset Management
IMNM icon

BNP Paribas Asset Management’s Immunome IMNM Stock Holding History

BNP Paribas Asset Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24M Buy
1,097,836
+915,457
+502% +$20.4M 0.03% 509
2025
Q4 		$3.92M Buy
182,379
+181,742
+28,531% +$3.19M ﹤0.01% 903
2025
Q3 		$7K Hold
637
– – ﹤0.01% 1736
2025
Q2 		$6K Buy
+637
New +$5.22K ﹤0.01% 1936

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

BNP Paribas Asset Management's IMNM Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Immunome (IMNM) stake by 502% in Q1 2026, buying an estimated $20.4M and bringing the position to 1,097,836 shares worth $24M. The position accounts for 0.03% of the portfolio, ranked #509.

BNP Paribas Asset Management first reported a position in IMNM in Q2 2025 and has held it in 4 quarters since. 201 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • BNP Paribas Asset Management held 1,097,836 shares of Immunome worth $24M as of Q1 2026.
  • BNP Paribas Asset Management bought 915,457 Immunome shares in Q1 2026, an estimated $20.4M.
  • Immunome made up 0.03% of BNP Paribas Asset Management's portfolio in Q1 2026, its #509 holding.
  • BNP Paribas Asset Management first reported a position in Immunome in Q2 2025 and has held it in 4 quarters since.
  • 201 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.